Clinical Trials at CascAids Research
During the past decade, CascAids Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at CascAids Research
According to Clinical.Site data, the most researched conditions in "CascAids Research" are
"HIV Infection" (2 trials). Many other conditions were trialed in "CascAids Research" in a lesser frequency.
Clinical Trials Intervention Types at CascAids Research
Most popular intervention types in "CascAids Research" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Background regimen" (1 trials), "EVG placebo" (1 trials), "Elvitegravir" (1 trials), "RAL placebo" (1 trials) and "Raltegravir" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CascAids Research
The vast majority of trials in "CascAids Research" are
2 trials for "All" genders.
Clinical Trials Status at CascAids Research
Currently, there are NaN active trials in "CascAids Research".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in CascAids Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CascAids Research, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".